The Effect of Hormonal Add-Back Therapy in Adolescents Treated With a GnRH Agonist for Endometriosis: A Randomized Trial
Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether a regimen of norethindrone acetate +
placebo or norethindrone acetate + conjugated estrogens is superior in maintaining skeletal
health and quality of life in adolescents treated with a GnRH agonist for endometriosis.
Phase:
Phase 2
Details
Lead Sponsor:
Boston Children's Hospital Boston Children’s Hospital